Mono-N-terminal poly(ethylene glycol)-protein conjugates

被引：244

作者：

Kinstler, O ^{[1
]}

Molineux, G ^{[1
]}

Treuheit, M ^{[1
]}

Ladd, D ^{[1
]}

Gegg, C ^{[1
]}

机构：

[1] Amgen Inc, Thousand Oaks, CA 91320 USA

来源：

ADVANCED DRUG DELIVERY REVIEWS | 2002年 / 54卷 / 04期

关键词：

poly(ethylene glycol); polymer-modified proteins; site-specific conjugation; therapeutic proteins;

D O I：

10.1016/S0169-409X(02)00023-6

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

A site-directed method of joining proteins to poly(ethylene glycol) is presented which allows for the preparation of essentially homogeneous PEG-protein derivatives with a single PEG chain conjugated to the amine terminus of the protein. This selectivity is achieved by conducting the reductive alkylation of proteins with PEG-aldehydes at lower pH. Working examples demonstrating the application of this method to improve the delivery characteristics and therapeutic value of several proteins are provided. (C) 2002 Published by Elsevier Science B.V.

引用

页码：477 / 485

页数：9

共 63 条

[1]

[Anonymous], [No title captured]

[2] Rational design of a potent, long-lasting form of interferon:: A 40 kDa branched polyethylene glycol-conjugated interferon α-2a for the treatment of hepatitis C [J].

Bailon, P ;

Palleroni, A ;

Schaffer, CA ;

Spence, CL ;

Fung, WJ ;

Porter, JE ;

Ehrlich, GK ;

Pan, W ;

Xu, ZX ;

Modi, MW ;

Farid, A ;

Berthold, W .

BIOCONJUGATE CHEMISTRY, 2001, 12 (02) :195-202

[3] IDENTIFICATION AND CLONING OF A MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR THAT IS A LIGAND FOR THE CYTOKINE RECEPTOR MPL [J].

BARTLEY, TD ;

BOGENBERGER, J ;

HUNT, P ;

LI, YS ;

LU, HS ;

MARTIN, F ;

CHANG, MS ;

SAMAL, B ;

NICHOL, JL ;

SWIFT, S ;

JOHNSON, MJ ;

HSU, RY ;

PARKER, VP ;

SUGGS, S ;

SKRINE, JD ;

MEREWETHER, LA ;

CLOGSTON, C ;

HSU, E ;

HOKOM, MM ;

HORNKOHL, A ;

CHOI, E ;

PANGELINAN, M ;

SUN, Y ;

MAR, V ;

MCNINCH, J ;

SIMONET, L ;

JACOBSEN, F ;

XIE, C ;

SHUTTER, J ;

CHUTE, H ;

BASU, R ;

SELANDER, L ;

TROLLINGER, D ;

SIEU, L ;

PADILLA, D ;

TRAIL, G ;

ELLIOTT, G ;

IZUMI, R ;

COVEY, T ;

CROUSE, J ;

GARCIA, A ;

XU, W ;

DELCASTILLO, J ;

BIRON, J ;

COLE, S ;

HU, MCT ;

PACIFICI, R ;

PONTING, I ;

SARIS, C ;

WEN, D .

CELL, 1994, 77 (07) :1117-1124

[4]

BENHAR I, 1994, J BIOL CHEM, V269, P13398

[5] MODIFICATION OF CD4 IMMUNOADHESIN WITH MONOMETHOXYPOLY(ETHYLENE GLYCOL) ALDEHYDE VIA REDUCTIVE ALKYLATION [J].

CHAMOW, SM ;

KOGAN, TP ;

VENUTI, M ;

GADEK, T ;

HARRIS, RJ ;

PEERS, DH ;

MORDENTI, J ;

SHAK, S ;

ASHKENAZI, A .

BIOCONJUGATE CHEMISTRY, 1994, 5 (02) :133-140

[6]

Chang M., 1995, Blood, V86, p368A

[7] SUBTILIGASE - A TOOL FOR SEMISYNTHESIS OF PROTEINS [J].

CHANG, TK ;

JACKSON, DY ;

BURNIER, JP ;

WELLS, JA .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (26) :12544-12548

[8] Therapeutic antibody fragments with prolonged in vivo half-lives [J].

Chapman, AP ;

Antoniw, P ;

Spitali, M ;

West, S ;

Stephens, S ;

King, DJ .

NATURE BIOTECHNOLOGY, 1999, 17 (08) :780-783

[9]

Coleman D., 1995, Blood, V86, p690A

[10] Pharmacokinetic analysis of pegylated megakaryocyte growth and development factor in humans [J].

De Boer, RH ;

Roskos, LK ;

Cheung, E ;

Fox, S ;

Basser, RL ;

Marty, J ;

Begley, CG ;

Cebon, J .

GROWTH FACTORS, 2000, 18 (03) :215-226

← 1 2 3 4 5 6 7 →